Key facts
activeHARKE Pharma GmbH
de
R1202_HRB14531
de
active
de
Xantener Straße 1, 45479 Mülheim an der Ruhr.
de
Company dossier
HARKE Pharma GmbH
RISK SCORE31MEDIUM RISK
Companies at this address
7 totalConnections
13 linksblueOcean Chemicals GmbHSyntana International GmbHCarefit GmbHHarke Group GmbHDiBu Power GmbHDB Investment GmbHHARKE SERVICES GmbHWH Aviation Verwaltungs-GmbHHARKE Türkei Verwaltungs-GmbHWH Aviation GmbH & Co. KGHARKE Chemicals GmbHSyntana International GmbHHARKE International Services GmbH & Co. KG
People with significant control
10 people| Name | Role | From | Source |
|---|---|---|---|
| Daniel Burchart | mit der Befugnis im Namen der Gesellschaft mit sich als Vert | — | Germany registry |
| Jörg Doctor Brunemann | mit der Befugnis im Namen der Gesellschaft mit sich als Vert | — | Germany registry |
| Dirk Doctor Schmalz | officer | — | Germany registry |
| Friedhelm Fieseler | officer | — | Germany registry |
| Jörg Doctor Brunemann | officer | — | Germany registry |
| Jörg Hans | officer | — | Germany registry |
| Michael Lier | officer | — | Germany registry |
| Monika Doctor Siebel | officer | — | Germany registry |
| Udo Schreiber | officer | — | Germany registry |
| Volker Scherges | officer | — | Germany registry |
Risk signals
2 matchedhigh
Business fragmentation
A director is shared across 15 companies — business-splitting (дробление) pattern
high
Phoenix predecessor
Shares a director with a failed, near-identically-named company (Harke Group GmbH · dissolved · name-sim 0.5) — phoenixing pattern (shed debts under a new company)
Risk journey — why 31?
2 signals+16
Business fragmentation
+15
Phoenix predecessor
Composite risk score31/100